Radiprodil in Participants With Hepatic Impairment

Clinical trial NCT07457229 · RECRUITING

Trial details

NCT number: NCT07457229
Sponsor: GRIN Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2026-03-03
Primary completion: 2027-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.